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LUBAC synthesizes linear ubiquitin chains
via a thioester intermediate
Benjamin Stieglitz, Aylin C. Morris-Davies, Marios G. Koliopoulos, Evangelos Christodoulou
& Katrin Rittinger+
Division of Molecular Structure, MRC-National Institute for Medical Research, London, UK
The linear ubiquitin chain assembly complex (LUBAC) is a RING
E3 ligase that regulates immune and inflammatory signalling
pathways. Unlike classical RING E3 ligases, LUBAC determines
the type of ubiquitin chain being formed, an activity normally
associated with the E2 enzyme. We show that the RING-
in-between-RING (RBR)-containing region of HOIP—the cataly-
tic subunit of LUBAC—is sufficient to generate linear ubiquitin
chains. However, this activity is inhibited by the N-terminal
portion of the molecule, an inhibition that is released upon
complex formation with HOIL-1L or SHARPIN. Furthermore, we
demonstrate that HOIP transfers ubiquitin to the substrate
through a thioester intermediate formed by a conserved cysteine
in the RING2 domain, supporting the notion that RBR ligases act
as RING/HECT hybrids.
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INTRODUCTION
The reversible modification of proteins with polyubiquitin chains
regulates a multitude of biological functions, and the type of
ubiquitin chain attached determines the biological outcome of the
modification [1]. Ubiquitin contains seven lysine residues all
of which have been shown to form ubiquitin chains in vivo.
K48-linked and K63-linked chains are at present the most
intensely studied type of modification and their roles in
proteasomal degradation (K48) [2], DNA repair [3] and cell
signalling (K63) [4] are well documented. More recently, a new
type of ubiquitin chain was identified, termed linear or M1-linked
ubiquitin chains, in which the carboxy-terminal glycine of one
molecule forms a peptide bond with the amino-terminal
methionine of another. This type of chain has been shown to
have an important role in the response to stimulation of the
tumour-necrosis factor, interleukin-1b and CD40 receptors and
the subsequent activation of the canonical NF-kB pathway, and is
catalysed by an E3 ubiquitin ligase complex called LUBAC (linear
ubiquitin chain assembly complex) [5]. LUBAC was initially
identified to be composed of the two RING-in-between-RING
(RBR) domain-containing proteins HOIL-1L (haem-oxidized
iron-regulatory protein 2 ubiquitin ligase-1) and HOIP (HOIL-
1L-interacting protein) [6]. More recently it was shown to contain
a third component, an ubiquitin-binding protein called SHARPIN
(Shank-associated RH domain-interacting protein) (Fig 1A).
SHARPIN provides the LUBAC complex with a biological activity
that is distinct from that of the original HOIP/HOIL-1L complex
but does not change the type of ubiquitin chain formed [7–9].
Ubiquitination occurs via an enzymatic cascade involving three
enzymes [10]. It is initiated by an E1 activating enzyme that forms
a reactive thioester with the C-terminal glycine of ubiquitin in
an ATP-dependent fashion. This thioester is passed on to an
E2-conjugating enzyme and finally transferred onto the substrate
by an E3 ubiquitin ligase. E3 ligases can be divided into two main
classes: HECT (homologous to E6AP carboxyl terminus)-type
ligases, which form a thioester with ubiquitin before the final
transfer onto the substrate, and the much larger family of RING
(really interesting new gene) ligases, which act as scaffolds to
bring the E2 and the substrate together [11]. Canonical RING
domains adopt a cross-brace structure and coordinate two Zn2þ
ions using conserved cysteine/histidine patterns. The RBR family,
which includes HOIP and HOIL-1L, is a subgroup of the RING
family of E3 ligases [12] but unlike all other RING E3s contains
three Zn2þ -binding modules: an N-terminal classical RING
(RING1), a central in-between-RING (IBR) domain, which also
coordinates two Zn2þ ions but adopts a fold different from RING
domains [13] and a C-terminal RING domain (RING2), which in
the RBR protein HHARI has been shown to bind only a single
Zn2þ ion with a topology different to that of the classical RING
finger (Fig 1B, 1WD2.pdb) [14]. At present, it is not known if
coordination of a single Zn2þ by RING2 is specific for HHARI or a
common feature of other RBR domains. For some members of this
RING subfamily it has been shown that the isolated RBR, or even
its subdomains, are sufficient for ubiquitin chain synthesis, such as
the IBR-RING2 of Parkin [15] or RING2 of HHARI [14]. In
contrast, HOIP, the catalytic subunit of LUBAC, is believed to be
only functional in complex with HOIL-1L and/or SHARPIN and no
active subdomains have been identified [5–9].
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Generally, it is assumed that the linkage specificity of the
ubiquitin chain is determined by the last thioester intermediate
formed [11,16]. This implies that HECT-type E3 ligases not only
select the substrate but also determine the chain linkage [17].
On the other hand, RING-type E3 ligases only mediate substrate
selection, while it is the E2 that determines chain linkage
specificity. In contrast, LUBAC, despite belonging to the RING
family, enforces the generation of linear ubiquitin chains
regardless of the cognate E2. A mechanistic explanation for this
unique behaviour is at present missing; however, the recent report
that HHARI is capable of forming a thioester between a conserved
cysteine in RING2 and the C-terminal glycine of ubiquitin
provided a first clue to a possible underlying molecular
mechanism and has led to the suggestion that RBRs might act as
RING/HECT hybrids [18].
Here, we investigate the molecular determinants that allow
LUBAC to enforce linear ubiquitin chain synthesis. We demon-
strate that the RBR-containing region of HOIP is sufficient to
catalyse the formation of linear chains and that the reaction
proceeds via a thioester intermediate formed by a conserved
cysteine residue in RING2. Importantly, we show transfer of this
thioester to a di-ubiquitin substrate forming a tri-ubiquitin product.
Furthermore, we establish that the region N-terminal to the RBR of
HOIP acts in an autoinhibitory fashion, which can be released
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Fig 1 | The composition of LUBAC and the activity of the RBRs. (A) Domain structure of the LUBAC subunits, with the domains mediating protein
interactions indicated. The colour coding used in this figure (HOIP in green and so on) will be maintained throughout the manuscript. (B) Sequence
alignment of RING2 domains and structure of HHARI RING2 (1WD2.pdb). Conserved cysteines that are involved in coordination of the Zn2þ are
indicated by * and the cysteine forming the thioester by A. This corresponds to Cys357 in HHARI and Cys885 in HOIP. (C) The RBR of HOIP
catalyses the synthesis of linear ubiquitin chains. In vitro ubiquitination assays with the RBR of HOIP using wt ubiquitin (left) or His6-ubiquitin
(right) as substrate. A star indicates assay components, mostly E2, that have not precipitated during acidification. (D) In vitro ubiquitination assays
covering different time scales with HOIL-1L using wt or His6-ubiquitin as substrate. The reaction conditions used were identical in C and D. Gels
were stained with Coomassie Blue. The constructs used in C and D are indicated schematically above the gels with the domains present in the assays
highlighted in colour in green for HOIP and blue for HOIL-1L. HOIL-1L, haem-oxidized iron-regulatory protein 2 ubiquitin ligase-1; HOIP, HOIL-
1L-interacting protein; LUBAC, linear ubiquitin chain assembly complex; RBR, RING-in-between-RING; RING, really interesting new gene; SHARPIN,
Shank-associated RH domain-interacting protein; UBA, ubiquitin-associated; UBL, ubiquitin-like; wt, wild-type.
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upon complex formation with HOIL-1L or SHARPIN, explaining
the earlier observation that HOIP is only active in complex with
HOIL-1L and/or SHARPIN.
RESULTS AND DISCUSSION
The RBR region of HOIP synthesizes linear chains
At present, our knowledge about the minimal structural units of
LUBAC that are required to promote linear ubiquitin chain
synthesis is limited, and it is believed that a complex between
HOIP and HOIL-1L or SHARPIN is required for activity [6–9].
We therefore decided to investigate the activity of the RING-
containing units, the RBRs, using an in vitro ubiquitination assay
and sequentially build up to the full-length complex in order to
identify the minimum linear chain catalytic machinery. These
experiments show that the C-terminal portion of HOIP containing
the RBR and a 140 amino acid extension that is required for
protein solubility (from now on referred to as RBR-C) is sufficient
to efficiently generate ubiquitin chains. In our assay, almost all
monoubiquitin is used up after 30min and polyubiquitin chains
with a length of more than 15 ubiquitin moieties are generated
(Fig 1C). Importantly, when the same assay was performed using
ubiquitin, which contains all seven lysine residues but with an
N-terminal His6-tag, no ubiquitin chains are formed, indicating
that the N-terminal Met of ubiquitin participates in the reaction
(Fig 1C). These data clearly demonstrate that the RBR-C of HOIP
catalyses the formation of linear ubiquitin chains with high
specificity and hence represents the activity observed in the
native LUBAC complex. Furthermore, we do not observe any
autoubiquitination of HOIP (supplementary Fig S1A online) and
therefore conclude that all chains formed are unattached.
In contrast to the RBR-C of HOIP, no chain formation was
observed with the RBR of HOIL-1L under the same conditions
(Fig 1D; supplementary Fig S1B online), in accordance with
a previous study indicating that HOIL-1L had no linear chain
assembly activity [6]. However, ubiquitination assays using
almost full-length HOIL-1L (only lacking a 32-residue C-terminal
flexible tail, from now on referred to as HOIL-1L, supplementary
Fig S1B online) showed some residual activity after 1 h prompting
us to follow the reaction over a longer time period (Fig 1D).
Ubiquitination assays run for up to 18 h clearly show that
HOIL-1L is, in principle, capable of forming high molecular
weight ubiquitin chains, but that the rate of chain formation is very
slow. Nevertheless, the chains formed are strictly linear as
indicated by the absence of any activity using His6-ubiquitin
as a substrate (Fig 1D). The observation that the full-length
protein has a higher activity than the isolated RBR is in clear
contrast to Parkin, another member of the RBR family, in which an
N-terminal ubiquitin-like (UBL) domain inhibits the activity
of the C-terminally located RBR [19] and indicates that
intramolecular interactions are not the reason for the low
activity of HOIL-1L.
HOIP is autoinhibited in the absence of HOIL-1L
Although activity of the isolated RBR has been shown for some
RING E3 ligases [14,15], the observation that the RBR-C of HOIP
is sufficient for the generation of linear ubiquitin chains was
unexpected as it has been reported that complex formation
between HOIL-1L and HOIP, mediated via their respective UBL
and ubiquitin-associated (UBA) domains, is required for efficient
chain synthesis [6]. To better understand the role of the domains
outside the RBRs and that of complex formation on the catalytic
activity of HOIP, we examined chain synthesis using increasingly
larger constructs of HOIP.
Interestingly, ubiquitination assays using a construct also
containing the UBA domain located N-terminal to the RBR show
a slower rate of ubiquitin chain synthesis (Fig 2A,B). This suggests
that the region N-terminal to the RBR interferes with catalytic
activity via an autoinhibitory interaction.
Interaction with HOIL-1L and SHARPIN releases inhibition
The interaction between HOIL-1L and HOIP occurs via their
respective UBL and UBA domains [6]. To quantify the binding
affinity, we performed isothermal titration calorimetry (ITC) using
the isolated domains, which resulted in a Kd value of 3.5 mM
(Fig 2C). It is tempting to assume that this interaction might
regulate the activity of HOIP. To test this hypothesis, we pre-
incubated the HOIP UBA-RBR tandem construct with the UBL of
HOIL-1L, and repeated the chain synthesis reaction. Indeed,
complex formation restored the activity back to the level of the
RBR-C (Fig 2D). This result suggests a model in which the UBL of
HOIL-1L competes with an autoinhibitory interaction between the
RBR and UBA of HOIP. However, we could not detect any
binding between these two domains in isolation by ITC
(supplementary Fig S2A online) or see inhibition in trans in
ubiquitination assays carried out in the presence of increasing
concentrations of the UBA (supplementary Fig S2A online),
indicating that the mechanism of autoinhibition is not analogous
to that identified in Parkin where inhibitory interactions can be
detected even in trans [19]. In fact, a tight binding between the
RBR and UBA might not be favourable for a competitive inhibition
mechanism, given that the UBL of HOIL-1L and the UBA of HOIP
interact in the low micro-molar range. Alternatively, it is possible
that the activation of HOIP involves a more subtle allosteric
regulation in a non-competitive fashion.
Remarkably, ubiquitination assays using a complex with HOIL-1L
instead of the isolated UBL not only restored the catalytic
activity to the level of the HOIP RBR-C but further increased
the rate of chain synthesis suggesting that HOIL-1L modulates
catalytic efficiency in a second distinctive way. Given the almost
negligible activity of HOIL-1L on the time scale of this experiment
it is unlikely that the increased activity is due to residual activity of
the HOIL-1L RBR (Fig 1D). Nevertheless, to formerly exclude this
possibility we repeated the assay with a catalytically inactive
HOIL-1L mutant C460A (supplementary Fig S2B online). To our
surprise, the activity of this mutant was decreased and comparable
to that of the isolated UBL (Fig 2F), suggesting that the RBRs of
HOIP and HOIL-1L modulate each other’s activity, possibly
via a direct interaction. Although we could not detect a direct
interaction between the isolated RBR domains (data not shown),
it is conceivable that UBA–UBL-mediated complex formation
might bring them into close proximity.
The recently identified LUBAC component SHARPIN has also
been shown to promote linear chain synthesis when bound
to HOIP. To examine if it is equally capable of releasing auto-
inhibition, we carried out ubiquitination assays using a much
longer construct of HOIP that includes the zinc finger region that
contains the binding site for SHARPIN (NZF2, see Fig 1) [7,8] and
is only lacking an N-terminal PUB (Peptide:N-glycanase/UBA or
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Fig 2 | Inhibition of the catalytic activity of HOIP by adjacent domains and release through complex formation with HOIL-1L. (A) Comparison of
ubiquitin chain synthesis by HOIP constructs containing the RBR (as Fig 1C) and (B) UBA-RBR. (C) ITC titration between the UBA of HOIP
and UBL of HOIL-1L. (D) Ubiquitination assay with a HOIP UBA-RBR/HOIL-1L UBL complex. (E) Comparison of the activity of a complex
between HOIP UBA-RBR and wt HOIL-1L versus (F) a complex with a catalytically dead HOIL-1L mutant (C460A). Stars indicate assay components
that have not precipitated during acidification. The colour coding and reaction conditions used are as in Fig 1C,D. HOIL-1L, haem-oxidized
iron-regulatory protein 2 ubiquitin ligase-1; HOIP, HOIL-1L-interacting protein; RBR, RING-in-between-RING; UBA, ubiquitin-associated;
UBL, ubiquitin-like; wt, wild-type.
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ubiquitin regulatory X (UBX)-containing proteins) domain of yet
unidentified function. This experiment shows that, similar to
HOIL-1L, SHARPIN is capable of releasing autoinhibition of HOIP,
although to a lesser extent than HOIL-1L (Fig 3), and supports the
notion that the release of autoinhibition of HOIP does not rely solely
on competition between its RBR and the UBL of HOIL-1L for
binding to the UBA of HOIP. Interestingly, the activities of HOIL-1L
and SHARPIN are not additive as no increase in the rate of chain
formation is observed with the trimeric HOIP/HOIL-1L/SHARPIN
complex (Fig 3). This observation indicates that the primary role of
SHARPIN in the LUBAC complex might not be to support the
catalytic machinery but rather to provide further functionality such
as substrate selection or possibly localization.
Ubiquitin transfer proceeds via a thioester intermediate
In contrast to RING E3 ligases, HECT ligases determine the linkage
specificity of the ubiquitin chain formed in a reaction that
proceeds via a thioester intermediate. It has recently been shown
that the RBR ligase HHARI also forms a thioester intermediate
leading to the suggestion that RBRs might be a new class of E3s
that act as RING/HECT hybrids [18]. At present, it is not clear if
this behaviour is a specific property of HHARI or if this hybrid
mechanism might apply more generally to RBR family proteins.
To investigate this possibility, we developed a fluorescence-based
ubiquitination assay aimed at trapping the thioester intermediate.
This assay is designed such that individual steps in the
ubiquitination cascade are visualized by following the activity of
a fluorescent, Cy5-labelled ubiquitin. This molecule can act as a
ubiquitin donor and form a thioester but is N-terminally blocked
and hence cannot accept an ubiquitin thereby preventing chain
formation. As shown in Fig 4A, incubation of Cy5-ubiquitin with
E1 and ATP results in the formation of a high molecular weight
adduct that is sensitive to treatment with a reducing agent
indicating that the E1-thioester has been formed (lanes 3 and 4).
Addition of E2 induces transthiolation of the ubiquitin onto the E2,
forming another dithiothreitol (DTT)-sensitive product (lanes 5 and 6).
Once the RBR-C of HOIP is added to this mixture the ubiquitin is
transferred onto the RBR, forming an adduct that is sensitive to
treatment with reducing agents, clearly demonstrating that the
reaction product formed is a thioester and not autoubiquitination
of the RBR-C (lanes 7 and 8). Importantly, addition of a
C-terminally blocked di-ubiquitin that can only act as a ubiquitin
acceptor to this mixture results in the quantitative transfer of
the activated ubiquitin from HOIP onto the substrate forming a
covalent product (lane 9) as indicated by its insensitivity to
reducing agents (lane 10). A gel stained for total protein content of
this reaction is shown in supplementary Fig S4 online.
The cysteine responsible for thioester formation in HHARI has
been identified as Cys357 [18], which is completely conserved
across RBRs but not involved in coordination of the Zn2þ ion in
HHARI (Fig 1B) [14]. At present it is not known if coordination of a
single Zn2þ ion by RING2 is specific for HHARI or a general
feature of RBRs as no structures are available for other RING2
domains. To test if the equivalent cysteine in HOIP, Cys885,
might also be forming the thioester, we mutated it to alanine
and tested its catalytic activity. This mutant was catalytically
inactive as shown in the Cy5-ubiquitin-based assay (Fig 4B) as
well as in the conventional in vitro ubiquitination assay
(supplementary Fig S3 online). To ensure that this loss of activity
is not due to unfolding of the protein, we made the corresponding
serine mutation (C885S) to test for formation of an oxyester.
As shown in Fig 4C, this mutant was active and formed an
adduct with HOIP clearly indicating that removal of Cys885 does
not trivially remove a residue required for Zn2þ coordination
resulting in unfolded protein. The adduct formed was insensitive
to treatment with DTT but undergoes acid-catalysed ester
hydrolysis (Fig 4C), demonstrating that it does not contain an
isopeptide linkage.
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Fig 3 | Comparison of linear ubiquitin chain synthesis by different LUBAC complexes. The gels show the increase in the rate of chain formation upon
addition of SHARPIN or HOIL-1L to a HOIP ZFs-UBA-RBR construct. There is no further increase in the rate of chain formation in the trimeric
complex. Stars indicate assay components that have not precipitated during acidification. HOIL-1L, haem-oxidized iron-regulatory protein 2
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CONCLUSIONS
We show here that the RBR-C of HOIP is sufficient to catalyse the
synthesis of linear polyubiquitin chains. However, this activity is
inhibited by the remainder of the protein but can be released upon
addition of HOIL-1L or SHARPIN, nicely explaining why earlier
studies could only detect activity in the context of the complex.
Furthermore, our data indicate that HOIL-1L not only releases
autoinhibition but can also synthesize linear ubiquitin chains.
Although the catalytic activity of HOIL-1L in isolation is very
slow, our data suggest that it becomes relevant in complex with
HOIP and contributes to the linear chain synthesis activity of
the heterocomplex via an as yet unidentified mechanism. It is
tempting to speculate that this might include a direct interaction
between the two RBRs of HOIP and HOIL-1L, brought into close
proximity by their respective UBA and UBL domains, similar to
those RING ligases that act as homo and heterodimers [20].
Our experiments have now shown that the RBR of HOIP forms a
thioester via a conserved cysteine in RING2, and we demonstrate
for the first time that this thioester intermediate is subsequently
transferred to a substrate. These data provide a first molecular
insight into the mechanism underlying the ability of LUBAC to
enforce the synthesis of linear ubiquitin chains. LUBAC
shows reactivity with a range of E2s, including UbcH7 that is
normally not active with RING E3 ligases. Taken together,
our data provide new evidence that the RING/HECT hybrid
mechanism suggested by Klevit and colleagues for the action of
HHARI [18] might be a more general mechanism for RBRs and
might require this RING subfamily to be reclassified within the
ligase superfamily.
METHODS
Protein expression, labelling and purification. All constructs used
in this study were expressed in pET-47b, pET-49b (Merck
Millipore) or pGEX-6P1 (GE Healthcare). Domain boundaries of
the constructs used are listed in supplementary information
online. All proteins used were purified by affinity chromatography
on glutathione sepharose (GST-tagged) or Ni-NTA Superflow resin
(His-tagged), followed by ion-exchange chromatography if
necessary (after removal of the GST-tag by Precission Protease)
and size-exclusion chromatography (SEC). Protein concentrations
were determined by ultraviolet spectrometry at 280 nm using
calculated extinction coefficients. Bovine mono-ubiquitin was
purchased from Sigma and further purified by SEC. His6-Cys-
ubiquitin was labelled with Cy5 maleimide mono-Reactive
Dye (GE Healthcare) according to the manufacturer’s instructions
and further purified by SEC. Further details are provided in
supplementary information online.
In vitro ubiquitination assays. Assays were performed with 1 mM
Ube1, 5–30 mM UbcH7 or UbcH5, 5–30mM of the relevant HOIP,
HOIL-1L and SHARPIN components and 200 mM ubiquitin in
buffer containing 50mM HEPES pH 7.5, 150mM NaCl, 20mM
MgCl2 and 10mM ATP. Reactions were incubated at 30 1C for 1 h
and samples taken at set time intervals. Further details of the assay
are in supplementary information online.
In vitro ubiquitination assays using Cy5-labelled ubiquitin. One
micromolar Cy5-ubiquitin was mixed with 2 mMUbe1 (lanes 1, 2),
and 1mM ATP was added to start the reaction (at 25 1C). After
10min, samples were taken (lanes 3, 4) and 10mM UbcH5 was
added. After 10min, samples were taken (lanes 5, 6) and 20 mM
HOIP was added. Samples were taken after 15 s (lanes 7, 8) to
detect the thioester, and 15 mM diUb-His6 was added and further
samples (lanes 9, 10) taken after 10min. To monitor formation of
the oxyester, the reaction was allowed to proceed for 15min and
carried out at 37 1C instead of 25 1C as oxyester formation is very
slow at the lower temperature. To hydrolyse the oxyester, the
reaction mixture was incubated for 1min in 4M urea followed by
incubation in 0.5M NaAc at pH 4 for 3min at 25 1C. Gels were
scanned with a Storm 860 Scanner (GE Healthcare).
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ubiquitin ligase-1-interacting protein; RBR, RING-in-between-RING; wt, wild-type.
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Isothermal titration calorimetry. ITC measurements were
performed using an ITC200 MicroCalorimeter (GE Healthcare).
All samples were dialysed into buffer containing 50mM HEPES
pH 7.5, 150mM NaCl and 1mM TCEP. Titrations were performed
at 20 1C with 50 mM of HOIP RBR or HOIL-1L UBL loaded into the
cell and 500 mM of HOIP UBA into the syringe. ITC data were
analysed with the Origin7 software (MicroCal) supplied by the
manufacturer.
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
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